Chargement en cours...
L-Type Calcium Channel blockers and Parkinson’s Disease in Denmark
OBJECTIVE: Investigate L-type calcium channel blockers of the dihydropyridine class for association with Parkinson’s disease because these drugs traverse the blood brain barrier, are potentially neuroprotective, and have previously been evaluated for impact on PD risk. METHODS: We identified 1,931 p...
Enregistré dans:
| Auteurs principaux: | , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2010
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2917467/ https://ncbi.nlm.nih.gov/pubmed/20437557 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ana.21937 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|